AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

Antimicrobial Chemotherapy
Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.

2013 Officers - all terms run from July 1, 2012 to June 30, 2013

Chair
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
hwexler@ucla.edu
310-268-3404

Chair-Elect
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Montville, NJ
jeff-lisa-alder@hotmail.com

Councilor
Linda A. Miller
GLAXOSMITHKLINE
Collegeville, PA
linda.a.miller@gsk.com
610-917-6280

Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms

Divisional Group Representative
Victor DiRita
University of Michigan
Ann Arbor, MI
vdirita@umich.edu


Join DivANet

Website

 

TPL_asm2013_SEARCH

91500